Sector context that changes what “done well” looks like.
The right technology answer in pharma is rarely the right answer in retail. We bring the operating context that makes the framework actually work for you.
Private Equity
The Challenge
Investment committees increasingly price technology risk directly into deal terms, yet most firms consider technology diligence as an afterthought — leaving synergy assumptions and integration costs unvalidated until after close.
Our Approach
We embed technology diligence directly into your investment process and carry the same team through to post-close value creation, so the synergy case that won the deal is the one your portfolio company actually delivers.
Technology
The Challenge
Technology and software targets face the deepest diligence of any sector — architecture, code quality, security posture, and key-person risk can each single-handedly move valuation.
Our Approach
Our technologist-led teams evaluate targets the way an acquiring engineering leader would — and outside a transaction, apply that same lens to help scaling software companies modernize architecture, streamline operations, mitigate risk, and retire technical debt before it ever surfaces in someone else's diligence.
Consumer Goods & Retail
The Challenge
Omnichannel platforms, legacy ERPs, and fragmented data across brands make integration slower and costlier than deal models assume — and customer-facing systems can't afford downtime during cutover.
Our Approach
We plan systems and data integration around the retail calendar and customer experience — sequencing cutovers to protect revenue in a deal, and modernizing the same omnichannel platforms and integrating systems and data assets on their own timeline when there's no transaction driving the clock.
Manufacturing & Automotive
The Challenge
OT/IT convergence, plant-floor systems, and multi-site ERP landscapes mean technology separation and integration touch physical operations, not just corporate IT.
Our Approach
We bring operating-model experience across plant and enterprise systems, so separation and integration plans account for production continuity — the same experience that lets us modernize OT/IT architecture and multi-site ERP landscapes for manufacturers with no deal underway at all.
Pharmaceuticals
The Challenge
Validated systems, regulatory data integrity, and GxP compliance requirements turn routine technology separation or integration into a compliance-critical undertaking.
Our Approach
We plan technology workstreams alongside regulatory and quality requirements from day one, so validated systems stay validated through separation, migration, and integration — or through an ordinary modernization program, where the same compliance discipline still applies.
Chemicals
The Challenge
Process-heavy operations, long-lived control systems, and complex global supply chains make technology roadmaps hard to prioritize against near-term operational risk.
Our Approach
We sequence technology investment against operational risk and asset lifecycle, giving leadership a roadmap that protects continuity while modernizing what actually drives cost and margin.